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Background: In many countries, Toxoplasma gondii (T. gondii) is a major cause of reproductive disorders and
abortions in the sheep industry, and therefore responsible for important financial and economic losses. In addition,
undercooked infected lamb is an important risk factor for human toxoplasmosis.
In the present study, the initial phase of the infection was investigated: the parasite ? s entry site, the subsequent
distribution of the parasite and the host-immune response.
Results: Parasite DNA was already detected in the cranial small intestinal mucosa the first days after oral infection with
T. gondii tissue cysts. Simultaneously, high IFN-gamma and IL-12 responses were induced mainly in the mesenteric
lymph nodes. The emergence of IgG1 (at 8dpi), and IgG2 (at 11 dpi) was accompanied by a decrease or even
disappearance of the IFN-gamma and IL-12 response in the Peyers? patches (PP), PBMC? s and popliteal LN? s. Meanwhile
the parasite DNA could be recovered from most mucosal and systemic tissues to become undetectable in the small
intestine, popliteal LN, PBMC and spleen 3 weeks pi.
Conclusions: Our results indicate that parasites enter the cranial small intestine the first days after infection and that
after an increase the first two weeks after infection, the parasite DNA levels in the intestine drop below the detection
limit three weeks after infection. This coincides with an increase in parastic-specific serum IgG1 and IgG2 and a decrease
of the antigen-specific IFN-gamma response in PP, PBMC and popliteal LN. We suggest a role for IFN-gamma and IL-12
in controlling the infection.
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Toxoplasma gondii is an obligate intracellular parasite
with a worldwide prevalence in a wide variety of hosts [1].
In many countries, the parasite is a major cause of repro-
ductive disorders, miscarriages and abortions in the sheep
industry, and therefore responsible for important financial
and economic losses [2,3]. Based on data collected by the
Veterinary Investigation Diagnosis Analysis in 2009 [4],
toxoplasmosis is the second cause of abortions in sheep in
the UK after Chlamydia abortus (45.6%).
Undercooked infected lamb is considered as an import-
ant risk factor for human toxoplasmosis [5]. Infection of
herbivorous animals occurs mostly through ingestion of* Correspondence: Delfien.verhelst@ugent.be
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unless otherwise stated.T. gondii oocysts excreted by cats. One week after a
first infection, cats can shed over 100 million oocysts in
their faeces during a period of 7? 14 days depending on
the infection dose, the infection stage and the immune
status of the cat. Sporulated oocysts can stay infectious
in the environment during more than 1 year and con-
taminate pastures, feeds and also drinking water [6,7].
An acute primary infection during gestation will result
in transmission of the parasite to the foetus. As in
humans, the consequences for the foetus depend on the
stage of the gestation: an early infection (during the first
or second trimester of gestation) results in fetal death and
resorption or abortion, whereas a later infection leads to
the birth of clinically normal but latently infected lambs or
of lambs with symptoms of congenital toxoplasmosis
(fever, growth retardation, weakness) [8-10].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Verhelst et al. BMC Veterinary Research 2014, 10:293 Page 2 of 12
http://www.biomedcentral.com/1746-6148/10/293The immunity developed by the pregnant ewe will
protect it against infection of the foeti during subse-
quent gestations [7]. The same protection seems to
occur when a non-pregnant ewe becomes infected with
T. gondii [10,11]. Data of Morley et al. [12,13] suggested
that immunity might protect less well against transpla-
cental transmission than thought. However, their studies
were based on T. gondii DNA detection only and not on
demonstration of T. gondii-associated lesions by histo-
pathology, nor did they exclude other abortifacient
agents [14]. Williams et al. [15] suggest that the observa-
tions of Morley et al. [12,13] are due to breed differ-
ences. Furthermore, the effectiveness of vaccination with
Toxo-Vax is mentioned in several studies [16-18].
Whereas several experimental infections have been
carried out in sheep to study host-immune responses, to
our knowledge, the distribution of the parasite and the
correlated antibody and interferon (IFN)-gamma re-
sponses during acute ovine toxoplasmosis have not been
studied yet [2,7,14,19-21].
In the present study, oral infections of sheep with T.
gondii tissue cysts were performed to determine the
entry site and subsequent distribution of the parasite
following the natural infection route. Furthermore, we
monitored the local IFN-gamma response during the
acute phase of the infection, because of its important
role as a mediator of host resistance against Toxoplasma
as demonstrated in mice, sheep and humans [17,22,23].
Methods
Animals and experimental procedure
Thirteen 7-week-old conventionally reared lambs were se-
lected (Belgian cross-breed, Zootechnical Centre, Leuven,
Belgium), based on their T. gondii and Neospora caninum
seronegative status. The absence of antibodies against T.
gondii was assessed by an indirect immunofluorescence
assay (IFA, Toxo-Spot IF, Biom?rieux, Marcy-l ? Etoile,
France). As anti-Neospora antibodies could cross-react
with T. gondii antigens, the sera were also tested with
the Neospora caninum Antibody Test Kit (CHEKIT*
Neospora, Idexx, Hoofdorp, The Netherlands).
After an acclimation period of one week at the experi-
mental animal facilities of Ghent University, eleven ani-
mals were orally infected with 3000 tissue cysts of the T.
gondii Prugniaud strain (PRU). PRU is a type II genotype
isolated from a case of human lethal congenital toxoplas-
mosis [24,25]. Sheep were killed by captive bolt and exsan-
guination on day 4 (4 dpi; N = 3), 8 (8 dpi; N = 2), 10 (10
dpi; N = 2), 14 (14 dpi; N = 1) and 21 (21 dpi; N = 3) after
infection. Two animals were kept as negative controls (C)
and euthanized at 21 days. Blood samples were taken daily
from the jugular vein of each animal until euthanasia for
monitoring the T. gondii-specific serum antibody re-
sponse. At euthanasia, portions of duodenal (D), jejunal(J) and ileal (I) tissue with and without Peyer ? s patches
(PP), the draining mesenteric lymph nodes (MLN), poplit-
eal lymph nodes, spleen and blood on heparin were sam-
pled. Samples were processed as described further to
determine the spread of the parasite as well as the appear-
ance of a specific IFN-gamma response in the different tis-
sues at the early phase of the infection.
All experimental and animal management procedures
were approved by the Animal Care and Ethics Committee
of the faculties of Bioscience Engineering and Veterinary
Medicine, Ghent University (2007/103).
Inoculum
Tissue cysts of the T. gondii PRU strain were harvested
from the brains of chronically infected C57BL6 mice and
quantified as described by Verhelst et al. [26]. Briefly, in-
fected mice were euthanized five weeks after infection and
their brains were homogenized in phosphate buffered sa-
line (PBS) using a Potter Homogenizer. The concentration
of brain cysts in the suspension was determined by phase
contrast microscopy whereafter the brain homogenate was
diluted in PBS to obtain a final concentration of 300 cysts
per ml. The sham inoculate given to the control animals
was prepared similarly from brains of non-infected mice.
Purification of recombinant antigens
The recombinant antigens GRA7, EC2 and MIC3234 ? 307
were used to stimulate cell suspensions for IFN-gamma
and IL-12 production. GRA7 has already been demon-
strated to be useful as a sero-diagnostic marker of acute
and chronic toxoplasmosis [27-29]. Furthermore GRA7
is expressed by all infectious stages of T. gondii and ap-
pears plentiful on the surface of the host cells, the host
cell cytosol, the parasitophorous vacuolar membrane
and lumen [30]. After rupture of the host cells, high
amounts of GRA7 come in contact with the host im-
mune system, triggering strong antibody responses [31].
The recombinant EC2 antigen is a chimer of the anti-
genic regions of the microneme proteins MIC2 and
MIC3 and of the surface antigen SAG1.
The recombinant antigens were produced as previ-
ously described [26,32]. Briefly, the HIS-tagged recom-
binant antigens were purified from an E. coli culture
using metal chelate affinity chromatography (Ni-NTA
Superflow, Qiagen, GmbH, Hilden, Germany), according
to the manufacturer ? s instructions. The recombinant an-
tigens were eluted from the Ni-NTA columns by incuba-
tion in 500 mM imidazol buffer followed by dialysis
through a CelluSep H1 membrane with a 8 kDa cut-off
(Membrane Filtration Products, Texas, USA) in urea
buffer for EC2 and GRA7 and in PBS for MIC3234 ? 307.
Toxoplasma total lysate antigen (TLA) was produced
as described before [33]. Briefly, T. gondii RH tachyzoites
(type I strain) were harvested from the peritoneal cavity
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fected 4 days earlier. Hereto, collected ascites fluid was
passed twice through a 26-gauge needle. After centri-
fugation for 15 minutes at 950 ? g, the pellet contain-
ing the tachyzoites was washed twice in PBS, followed
by sonication in an Ultrasonic disintegrator (MSE,
Leicester, United Kingdom) to solubilize the T. gondii
tachyzoite antigens. The total protein concentration
was measured by the bicinchoninic acid (BCA) reac-
tion (Thermo Scientific Pierce BCA Protein Assay Kit),
whereafter the antigen suspension was aliquoted and
stored at −20?C until use.
Indirect Immunofluorescence Assay (IFA)
To test for the presence of specific IgG and IgM anti-
bodies against T. gondii; the sheep sera were diluted 1:50
in PBS and tested as follows: fifty microliter of this
dilution was applied on a slide coated with formalin-
treated T. gondii RH tachyzoites (Toxo-Spot IF, Biom?rieux,
Marcy-l? Etoile, France) for 30 min at 37?C. On each slide,
seronegative and seropositive sheep reference serum sam-
ples were used as controls. After washing with PBS, 30 μl
of a 1:25 in PBS-Evans Blue diluted fluorescein isothio-
cyanate conjugated rabbit anti-sheep IgM or rabbit anti-
sheep IgG (KPL, Maryland, USA) was applied for 30
minutes at 37?C. The slides were then washed again, air-
dried and read using a fluorescence microscope.
T. gondii -specific antibody ELISA
The presence of T. gondii antigen-specific IgG, IgG1, IgG2
and IgA in the collected sera was tested by ELISA. Nunc
maxisorp immunoplates (Life Technologies, Merelbeke,
Belgium) were coated overnight at 4?C with TLA at a con-
centration of 10 μg/ml in bicarbonate coating buffer
(pH 9.7). In subsequent steps, the plates were blocked dur-
ing 2 hours at 37?C in 1% non-fat milk powder in PBS, in-
cubated for 1 h at 37?C with 100-fold diluted sera in PBS
with 0.05% Tween? 20 and 1% non-fat milk powder. This
was followed by an incubation step for 1 h at 37?C with
rabbit anti-sheep IgG- or IgA-labelled with horseradish
peroxidase (AbD Serotec (Gentaur), Brussels, Belgium); or
with a mouse anti-bovine IgG1 or IgG2 secondary anti-
body followed by an incubation with an anti-mouse
immunoglobulin-horseradish peroxidase conjugate. Subse-
quently a 3,3′,5,5′-tetramethylbenzidine solution (TMB)
(Sigma? Aldrich, Diegem, Belgium) was added. In between
each step, plates were manually washed 5 times with PBS
0.05% Tween? 20. The reaction was stopped by adding
50 μl 2 M H2SO4 (stop solution). Absorbance was read at
450 nm. Positive and negative control sera were included
on each plate. The corrected optical density (OD) was cal-
culated as: OD of sample ? OD of negative control sam-
ple. The serum samples were considered positive when
the corrected optical density (OD450) of the dilutionsexceeded the cut-off value (= mean OD450 (negative con-
trols) + 3 ? its standard deviation). The negative control
sera in the IFA and ELISA were from T. gondii negative
sheep. They tested negative in the Modified Agglutination
test, the IFA and the Sabin Feldman Dye Test.
Isolation of mononuclear cells (MCs) from blood, spleen,
lymph nodes and intestine
The MCs from blood and spleen were isolated as de-
scribed by Verhelst et al. [26]. The peripheral blood MCs
(PBMCs) were isolated by density gradient centrifugation
using Lymphoprep? (Nycomed, Brussels, Belgium). Briefly,
heparinized blood was centrifuged during 25 min at
1000 ? g and 18?C. After removing the plasma layer, the
buffy coat and erythrocyte pellet were suspended in an
equal volume of PBS with 1 mM ethylediaminetetraacetic
acid (PBS-EDTA) and layered onto the gradient. Tubes
were centrifuged for 45 min at 800 ? g and 18?C. The
interface layer, containing the MCs, was collected and the
cells were washed in PBS-EDTA.
Splenocytes were isolated from the spleen after remov-
ing the surrounding fat. The obtained cell suspension
was further purified by lysing the erythrocytes in the
presence of ammonium chloride. After centrifugation
(380 ? g at 18?C for 10 min), the pelleted cells were
washed and resuspended in PBS-EDTA (1 mM).
The MCs from mesenteric lymph nodes (MLN), pop-
liteal LN, duodenal, jejunal and ilial Peyers Patches (PP)
were isolated as described by Vandenbroeck et al. [34]
and the MCs from the duodenal, jejunal and ileal lamina
propria as described by Vande Walle et al. [35]. All
isolated cells were resuspended at a final concentration
of 1 ? 10 7 cells/ml in complete leucocyte medium (RPMI
1640, Gibco, Merelbeke, Belgium) supplemented with
10% fetal calf serum (FCS, Greiner Bio-One, Belgium),
200 mML-glutamin (Gibco), 100 U/ml penicillin and
100 μg/ml streptomycin (P/S; Gibco), 100 mM non-
essential amino acids (Gibco) and 100 μg/ml kanamycin
(Gibco).
Isolation of enterocytes from the intestine
At euthanasia, duodenal, jejunal and ileal segments with-
out PP of approximately one meter were sampled,
flushed three times with Krebs buffer (0.12 M NaCl,
0.014 M KCl, 0.001 M KH2PO4, 0.025 M NaHCO3,
pH 7.4) at room temperature and filled for 95% with
Hank ? s Buffered Salt Solution (HBSS) supplemented with
1.5 mM EDTA +1 mM 1,4-dithiothreitol (DTT) pre-
heated at 37?C. Then the segments were incubated in 2
liter PBS for 15 min at 37?C. Thereafter, the contents
were collected and placed at 4?C. This process was re-
peated twice. The isolated cells were pooled and washed
three times with HBSS supplemented with 0.1 mM phe-
nylmethylsulfonyl fluoride (PMSF). PMSF is a serine
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proteins [36]. After centrifugation for 10 min at 1800 ? g
and 4?C, the cells were resuspended in complete medium
at a concentration of 107 cells/ml.
Detection of parasite DNA in cell populations by real-time
PCR
DNA was extracted from cell suspensions using the
Qiagen QIAmp DNA Mini kit (Qiagen GmbH, Hilden,
Germany), according to the manufacturer ? s instructions.
Next, the presence of T. gondii DNA was determined by
duplex qPCR analysis as described before [37]: the T.
gondii repeat element (AF146527) was used as target for
the detection of the parasite ? s DNA and the amplifica-
tion of the cellular 18S rRNA gene Since host cells are
always present in the sample, the latter reaction should
always be positive. Tenfold dilutions of a counted num-
ber of RH tachyzoites and cultured swine kidney cells
(SK-6) were used to generate a standard line for the
quantification of T. gondii parasite DNA and one for the
cells, respectively. Real-time PCR was performed with an
initial 3 min denaturation step at 95?C, followed by
45 cycles at 95?C for 15 sec and 60?C for 20 sec.
Restimulation of isolated mononuclear cells with T. gondii
antigens
The MCs were seeded in 96-well flat bottom cell culture
plates (Greiner bio-one) at 106 cells/ per 100 μl complete
medium and per well. After an initial incubation of 12 h,
the mitogen concanavalin A (Con A) (5 μg/ml) (BD Bio-
sciences) or 10 μg/ml of one of the following antigens was
added: rEC2, rGRA7, rMIC3 or, total lysate antigen (TLA).
The recombinant proteins were diluted in complete me-
dium, supplemented with 10 μg/ml polymyxin B to
neutralize potentially contaminating endotoxin [38]. After
a 6 h incubation at 37?C in a humidified atmosphere with
5% CO2 for Con A or 96 h for the antigens, the cell-free
supernatant was removed and stored at −20?C until ana-
lysed for interferon-gamma (IFN-gamma) concentration
by ELISA.
Cytokine ELISA
To determine the IFN-gamma and interleukin 12 (IL-12)
concentrations in the cell-free culture supernatants, 96-
well Nunc maxisorp immunoplates (Life Technologies)
were coated overnight at 4?C with a mouse anti-bovine
IFN-gamma monoclonal antibody (mAb) (CC330; AbD
Serotec) at 5 μg/ml or with a mouse anti-bovine IL-12
mAb at 2.5 μg/ml (CC301; AbD Serotec), respectively.
Then, the plates were blocked for 2 h at room
temperature (RT) with PBS containing 0.05% Tween? 20
and 3% non-fat milk powder. In subsequent steps we
added each for 1 h at RT: 100 μl of cell culture super-
natant 1:2 in PBS supplemented with 0.05% Tween? 20and 1% non-fat milk powder, a biotin-labelled mouse
anti-bovine IFN-gamma mAb (CC302b; AbD Serotec)
or a biotin-labelled mouse anti-bovine IL-12 mAb
(CC326; AbD Serotec) and horseradish peroxidase (HRP)-
conjugated streptavidin (Abd Serotec). In between each
step, plates were washed 5 times with PBS supplemented
with 0.05% Tween? 20. Then, a HRP substrate solution
(3,3′,5,5′-tetramethylbenzidine (TMB, Sigma ? Aldrich))
was added for 30 min at RT in the dark. The reaction was
stopped by adding 50 μl H2SO4 (2 N) and the optical
density (OD) was measured at 450 nm.
The IFN-gamma and IL-12 concentrations in the cell
culture supernatants were calculated from a regression line
using the DeltaSoft JV 2.1.2 software. The regression lines
were obtained by including in the tests 10-fold dilutions of
recombinant ovine IFN-gamma or IL-12 starting from
4000 pg/ml and 320 u/ml, respectively. The recombinant
ovine IFN-gamma and ovine IL-12 were prepared as a
serum-free conditioned medium from transfected CHO
cells, according to a protocol described for the production
of recombinant ovine IL-4 [39]. The recombinant ovine
IFN-gamma was quantified using the recombinant bovine
IFN-gamma standard sold by Endogen, Thermo-scientific
(Rockford, USA) and the anti-bovine mAbs clones CC330
and CC302b (AbD Serotec) in a species cross-reactive
ELISA (personal communication with Sean Wattegedera,
Moredun Research Institute).
Results
Neospora caninum antibodies
None of the control or experimentally infected animals
showed IgG response against N. caninum at euthanasia.
Presence of T. gondii in tissues
The presence of T. gondii in the various tissues collected
after euthanasia was evaluated by qPCR (Table 1). At
4 days post infection (dpi), parasite DNA could be found
sporadically in tissues of two out of three sheep. These
sheep had T. gondii DNA in their epithelium (entero-
cytes, lamina propria) and in the organized lymphoid
tissue of the small intestine (PP) or draining the small
intestine (MLN), mostly in the cranial parts. In one
sheep the parasite could be detected in peripheral blood
mononuclear cells (PBMC). In the third sheep, no T.
gondii DNA was detected, suggesting that the parasite
had not yet invaded the gut at this time point, had
already left this site, or that the parasitic load was still
below the detection limit. In the sheep analysed at 8 dpi,
more tissues were found positive for T. gondii DNA.
The epithelium and draining lymph nodes of both sheep
were positive throughout the small intestine, the lamina
propria and Peyer ? s patches in the duodenum. Other
parts of the small intestine, popliteal lymph nodes and
spleen were positive in only one sheep. This presence in
Table 1 Presence of parasite DNA in different small intestinal tissues, lymph nodes and blood of sheep orally infected
with 3000 T. gondii PRU tachyzoites and euthanized at different days post infection (dpi)
Time
Parasite load as determined by RT qPCR and expressed as log 10 of parasite DNA/106 cells
DPI 4 8 10 14 21
Animals Sh1 Sh2 Sh3 Sh4 Sh5 Sh6 Sh7 Sh8 Sh9 Sh10 Sh11
Duodenal E 0,36 nd nd 3,06 -2,26 -3,06 -2,23 -2,90 nd nd nd
Duodenal LP -0,43 nd nd 2,88 -1,60 -1,46 -2,59 2,74 nd nd -1,58
Duodenal PP nd 0,11 nd 2,26 -1,15 -2,68 -0,74 4,09 nd nd nd
Jejunal E nd nd nd 2,23 -0,64 nd -2,67 -1,54 nd nd -0,67
Jejunal LP nd nd nd nd -0,02 -1,67 nd -1,96 nd nd nd
Jejunal PP nd nd nd nd -1,23 nd -2,07 3,40 nd nd nd
Ileal E nd -0,16 nd 0,87 -1,44 nd -3,29 -1,86 nd nd nd
Ileal LP nd nd nd nd -0,44 -1,91 -4,00 -2,10 nd nd nd
Ileal PP nd nd nd nd -2,00 nd nd 2,95 nd nd nd
Duodenal MLN 0,34 nd nd 1,95 -0,31 -1,20 -0,77 2,76 0,05 nd nd
Jejunal MLN 2,63 nd nd 1,45 -0,51 -0,99 -0,94 3,67 8,37 nd nd
Ileal MLN nd nd nd 2,44 -0,72 -2,87 -1,06 3,19 -1,29 nd nd
Peripheral blood MC 0,45 nd nd nd nd nd -1,68 -1,30 nd nd nd
Popliteal LN nd nd nd nd -1,54 -1,66 -0,89 nd nd nd nd
Splenocytes nd nd nd nd -2,49 nd -2,00 nd nd nd nd
Sh = Sheep. E = Enterocytes. LP = Lamina propria. PP = Peyers ? patches. MLN =Mesenteric lymph nodes. MC =Mononuclear cells. LN = Lymph node.
Nd = Not detected.
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ring. At 10 dpi a similar pattern was seen for the intes-
tinal tissues and MLN, but now both euthanized animals
showed parasite DNA in their popliteal lymph nodes,
confirming the dissemination observed in one sheep at
day 8. At 14 dpi the only euthanized animal had parasite
DNA in all its intestinal tissues with the highest
amounts in the Peyer ? s patches and MLN, whereas pop-
liteal lymph nodes and spleen were negative. One week
later (21 dpi), the parasite load had dropped below the
detection limit in most tissues. In one animal only para-
site DNA was demonstrated in its MLN with the highest
amounts in jejunal MLN. The other animal had low
levels of parasite DNA in its jejunal epithelium and duo-
denal lamina propria. The third sheep tested negative.
This suggests that either most of the parasites had left
the intestinal and lymphoid tissues or were cleared from
these tissues at this time point.
When comparing the parasitic load in the tissues of
the four animals euthanized at 8 and 10 dpi a trend
could be observed in cranial versus caudal intestinal tis-
sues. For each of the four animals, one or more of the
tested duodenal tissues or its associated draining lymph
node, showed the highest or second highest amount of
parasite DNA, while the tested ileal tissues often showed
the lowest amount. In 5 of 12 ileal tissues samples even
no parasite DNA could be detected at all. Overall the
ileal Peyer ? s patches showed the lowest amount ofparasite DNA. These data suggest that shortly upon re-
lease from the cysts, the parasite invades the gut primar-
ily in the cranial small intestine.
The two sham infected animals remained T. gondii-
free in all tissues.
Humoral immune response
The kinetics of the antibody response after the oral in-
fection was determined on sera collected daily. Both a
Toxoplasma-specific IgM and IgG IFA as a TLA-specific
IgG, IgG1, IgG2 and IgA ELISA were performed. Data of
the TLA-specific IgG ELISA are presented in Figure 1.
Toxoplasma-specific IgM was first detected at 9, 12
and 15 dpi, in three of the then 6 non-euthanized sheep
(3/6), two on 4 sheep (2/4) and two on 3 sheep (2/3),
respectively. In one sheep no specific IgM could be
detected until euthanasia at 3 weeks post infection. IgG
was detected by IFA in one sheep at 9 dpi (1/6) and in
another sheep at 12 dpi (1/4). These animals remained
seropositive until euthanasia.
In ELISA, the T. gondii-specific IgG was detected first
at 7, 8, 10 and 15 dpi, each time in one animal and
remained present in these animals until euthanasia.
Interestingly, in one animal no TLA-specific IgG re-
sponse was seen although parasite DNA could be de-
tected in its tissues at euthanasia 21dpi. IgG1 appeared
in one sheep 15 dpi and in another sheep 17 dpi. IgG2
appeared in the same two animals, but slightly earlier,
Figure 1 IgG response of the sheep in TLA ELISA in function
of time.
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sheep did not show T. gondii-specific antibodies in IFAT,
nor in ELISA.
Interferon-gamma and interleukin-12 cytokine response
At euthanasia, MCs were isolated from blood, Peyer ? s
patches, MLN, popliteal lymph nodes and spleen and re-
stimulated with rGRA7, rEC2, rMIC3 and total lysate
antigen (TLA) to determine the antigen-specific IFN-
gamma and/or IL-12 responses.
At 4 dpi, TLA, EC2 and MIC3 consistently induced high
IFN-gamma concentrations in the MLN cultures of all 3
animals, with the highest responses against MIC3 (DMLN:
80,637 ng/ml (mean) ? 61,951 (SEM); JMLN: 1,313,771
ng/ml ? 735,659; IMLN: 2,963,760 ng/ml ? 2,275,224),
followed by EC2 (DMLN: 5,400 ng/ml ? 2,204; JMLN:
129,964 ng/ml ? 119,802; IMLN: 298,194 ng/ml ? 155.314)
and TLA (Figure 2). In contrast, GRA7 less consistently in-
duced IFN-gamma (Figure 2): 2 out of 3 animals showed
IFN-gamma production in jejunal and ileal MLN and 1
out of 3 in duodenal MLN. IFN-gamma was also induced
in popliteal LN and spleen, but mainly by MIC3 and to a
lesser extent by TLA. Responses in PP and PBMC were
absent.
At 8 and 10 dpi, the IFN-gamma pattern was com-
pletely different with mostly low or no responses in
MLN, but responses more localized in PP, PBMC and
popliteal LN with the highest concentrations following
TLA stimulation and lower responses following GRA7
stimulation. Neither EC2, MIC3 nor TLA induced IFN-
gamma responses in the MLN cell cultures. Only GRA7
induced IFN-gamma in MLN of all 4 animals with the
lower concentrations at 8 dpi (Figure 2). GRA7 also in-
duced IFN-gamma production in popliteal LN cell cul-
tures of 3 out of 4 animals, and in PBMC and spleen cellcultures in 2 out of 4 animals, but it did not induce IFN-
gamma in PP cell cultures. Only TLA induced IFN-
gamma in PP cell cultures of all 3 small intestinal sites in
2 out of 4 animals. The same 2 animals showed TLA-
induced IFN-gamma in popliteal LN and PBMC cultures.
At 14 and 21 dpi, the IFN-gamma response was also pro-
nounced in the MLN and to a lesser extent in the spleen,
with mainly MIC3 inducing good responses in MLN,
whereas especially TLA gave high responses in the spleen.
TLA and GRA7 induced-responses were absent in PP,
popliteal LN and PBMC cultures, whereas low TLA
induced-responses could be seen in spleen cell cultures of
3 on 4 animals (one sheep euthanatized at 14 dpi and 2 at
21 dpi) and low MIC3 and EC2-induced-responses in 2 on
4 animals (at 21 dpi). All 4 animals showed IFN-gamma
responses induced by TLA, EC2, MIC3 and GRA7 in at
least one of their MLN cultures, but responses were lower
than those seen at 4 dpi. There was no IFN-gamma in-
duced in the MCs of the control animal.
Comparable to IFN-gamma, IL-12 production at day 4
was most consistently induced in the MLN cell cultures
(Figure 3). However, whereas GRA7 was the weakest in-
ducer of IFN-gamma, in JMLN it was the best inducer
of IL-12 (0.50 u/ml ? 0.16 (SEM)), followed by EC2 (0.29
u/ml ? 0.07 (SEM)), MIC3 (0.26 u/ml ? 0.06 (SEM)) and
TLA (0.06 u/ml ? 0.02 (SEM)). The latter induced low
amounts of IL-12 in DMLN of one animal and in JMLN
of another animal. Besides, low amounts of IL-12 were
induced by MIC3 in PP of two animals, by TLA in the
PP of the third animal and by EC2 in the popliteal LN of
one animal.
At 8 and 10 dpi, the responses of MLN were overall
lower except for one animal in which TLA induced 7.4
u/ml in jejunal MLN and EC2 10.1 u/ml in ileal MLN.
Neither of the antigens consistently induced IL-12 re-
sponses in the MLN cell cultures, but in each animal at
least one antigen induced IL-12 in at least one of the
MLN cell cultures (Figure 3). The same was seen for the
PP cell cultures. In popliteal LN cell cultures and spleen,
two of the 4 animals showed IL-12 production following
restimulation with different antigens. PBMCs remained
IL-12 negative. So at these time points more variation
was seen in the IL-12 response than in the IFN-gamma
response.
At 14 dpi, EC2 induced IL-12 in cell cultures of all tis-
sues except of spleen, with high concentrations in duo-
denal MLN (40.9 u/ml) and extremely high concentrations
in popliteal LN cell cultures (635,62 u/ml). None of the
other antigens induced IL-12 in MLN cell cultures
(Figure 3). For the PP, GRA7 and MIC3 induced IL-12 in
duodenal, EC2 in jejunal and MIC3 and TLA in ileal PP
cell cultures. Besides EC2, TLA induced also high IL-12
concentrations in the popliteal LN cell cultures (32.8 u/ml).
MIC3, GRA7 and TLA induced IL-12 in PBMCs and
Figure 2 IFN-gamma response (log10 scale) in mesenteric lymph nodes, Peyer? s Patches, popliteal LN and PBMC against GRA7, TLA
and MIC3 in function of time.
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Figure 3 IL-12 response (u/ml) in mesenteric lymph nodes against GRA7, TLA, MIC3 and EC2 in function of time.
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response in popliteal LN and PBMCs was a noteworthy
difference with the IFN-gamma response.
At 21 dpi, the IL-12 response was absent in popliteal
LN and PBMCs, was present in the splenocytes culture
of one animal stimulated with EC2 and MIC3 and was
consistently present in low concentration in duodenal
and jejunal MLN cultures stimulated with the recombin-
ant antigens and TLA (Figure 3). It was less consistently
present in ileal MLN cultures, similar to the IFN-gamma
response.
Discussion
T. gondii seropositive sheep are probably latently in-
fected for life and harbor tissue cysts in various tissues.
Therefore, the consumption of un- or undercooked meat
from seropositive animals is a high risk for humans [2].
In the present study a type II strain was used for experi-
mental infection of sheep since type II strains are most
commonly found in animals in Europe and are most
commonly identified as a cause of human toxoplasmosis
world-wide [40]. A live intramuscular vaccine (Toxovax?,MSD Animal Health) that is on the market can prevent
congenital toxoplasmosis in sheep. However, no current
vaccine can prevent infection, suggesting that new vac-
cination strategies are needed. Since T. gondii infection
of sheep mostly occurs via the oral route, inducing mu-
cosal protection against the infection might be import-
ant. Therefore insights are needed in the acute events
in the small intestine following oral infection [8,41].
Whereas several natural and experimental T. gondii
infections have been performed in sheep, none focused
in the same detail on the initial phase of the infection
at the intestinal mucosa and lymphoid tissues and its
local cytokine response as our study did [2,7,21,42-45].
In our study, sheep were orally infected with 3000
tissue cysts. Because infectious oocysts are more difficult
to obtain in sufficient quantities, lead to environmental
contamination and are a serious risk for laboratory
personnel, tissue cysts where used even though oral in-
fection in sheep mostly occurs via ingestion of oocysts
during grazing [46]. Nevertheless infection with tissue
cysts can occur, although rare, when sheep eat the pla-
centa or abortion products from ewes that aborted as a
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a few studies analyzed the immune response in sheep,
three of them after oral inoculation with oocysts [42,45,50]
and four following an intraperitoneal injection with tachy-
zoites of the RH strain or S48 strain [17,51-53]. The latter
is a non-natural infection. One other study analyzed the
immune after a subcutaneous infection with tissue cysts, a
non-natural infection route [54].
T. gondii tachyzoites preferentially entered the cranial
small intestine around 4 dpi. Most likely, infection oc-
curs at the same site when oocysts are given orally.
Indeed, Dubey and Sharma [55] found that excystation
of oocysts and the release of sporozoites takes place in
the small intestine.
Since parasites were detected simultaneously in epithe-
lial cells, lamina propria, MLN and blood in one sheep
at 4 dpi, our findings suggest that some parasites most
likely directly pass the epithelial barrier to reach MLN
and blood. This early detection of parasite DNA in blood
could be a consequence of the use of tissue cysts for oral
infection, which might pass the epithelial layer more
early than when infection occurs with oocysts, since
Dubey and Sharma [55] detected parasitaemia between 6
and 11 days after orally inoculating sheep with oocysts
[55]. Four days after infection, sheep were still IgM and
IgG seronegative in IFA and IgG negative in TLA ELISA.
However, stimulation of mesenteric lymphocytes and
splenocytes from animals infected 4 days earlier induced
a significantly higher IFN-gamma response than when
tested later. The response at day 4 is too early to be the
result of antigen-specific CD4+ and/or CD8+ T lympho-
cytes. A T-cell independent IFN-gamma production by
NK-cells [56] and CD4+ T cells [57] has been described
in mice and is dependent on the production of IL-12
and tumor necrosis factor-alfa (TNF-alfa) by macro-
phages [58]. In the present study, a generalized but low
IL-12 production was measured in the MLN cultures at
4 dpi. During this early infection stage, the parasite trig-
gers several components of the innate immune system.
Macrophages, NK cells, dendritic cells as well as neutro-
phils release cytokines such as IL-12 and IFN-gamma as
a result of the infection. This early produced IFN-
gamma is most likely crucial for inducing resistance
against the parasite [59,60]. Previous mouse studies have
demonstrated that IL-12 production is critical to induce
IFN-gamma production and protection against T. gondii.
Indeed, in IL-12p35/p40 knockout mice, IFN-gamma
levels were severely decreased and Toxoplasma gondii
tachyzoites underwent uncontrolled replication, which
most likely caused early death of the IL-12 deficient
mice [61]. While triggering the innate immune system,
parasite antigens are also taken up and presented by
antigen-presenting cells, leading to a parasite-specific
T-cell immunity [62].At 8 dpi, parasite DNA was highly present in the tissues
of the cranial small intestine and MLN and this remained
so until 14 dpi, suggesting replication of the parasite in the
small intestinal mucosa, mucosa-associated lymphoid tis-
sues and associated draining lymph nodes. This is consist-
ent with the observations of Dubey and Sharma [55] who
found tachyzoites in the mesenteric lymph nodes of sheep
from 7 dpi onwards. Also in mice an increase in parasite
burden occurs in PP, MLN, IE and LP between 4 and 9
dpi [63]. Specific IgM and IgG antibodies appeared almost
simultaneously 9 dpi,. Specific antibodies in the presence
of complement can lyse and therefore clear extracellular
tachyzoites [59]. Parallel with the appearance of anti-
bodies, a significant decrease in the IFN-gamma response
and a decrease in the IL-12 response were observed.
Different antigens induced IL-12 in different gut tissues of
different sheep. This was not the case for IFN-gamma.
GRA7 quite consistently induced IFN-gamma in MLN
lymphocyte cultures of the four animals tested at 8 and 10
dpi, whereas TLA clearly induced IFN-gamma in the PP
lymphocyte culture of two of the four euthanized animals.
This suggests that different antigens were involved in the
induction of the IFN-gamma responses in PP versus
MLN. Homing of the activated T cells from both lymphoid
tissues to other sites could explain why both antigen prep-
arations induced responses in PBMC and popliteal LN cell
cultures. Such homing at 8 dpi is consistent with the
increase of IFN-gamma producing CD4+ lymphocytes in
efferent lymph of surgically cannulated experimentally
infected lymph nodes at 11 dpi [52]. Our results suggest
that a T cell independent response becomes replaced by
an antigen-specific T lymphocyte response around 8 dpi.
That several antigens induced IFN-gamma and IL-12
responses in popliteal lymph nodes and spleen cell
cultures, distant systemic lymphoid tissues, supports for
systemic migration of the parasite.
Our observation that the parasite DNA disappears
from the small intestine, popliteal LN and PBMC and
spleen 3 weeks after infection, indicates that the parasite
load drops below the detection limit of the PCR. Indeed,
a negative result in PCR does not imply that these tis-
sues are completely free of parasite DNA. However, that
most of the tested tissues became PCR negative could be
an indication that the parasite is either suppressed in
these tissues, cleared from these tissues or otherwise is
leaving these tissues between 2 and 3 weeks post infec-
tion. This coincided with the significant increase of IgG
antibodies between 9 and 21 dpi.
In previous studies, the immune response was studied
following oral inoculation with oocysts or following intra-
peritoneal injection with tachyzoites of the RH strain
[64,65]. Whereas antibodies were detectable 14 dpi follow-
ing oral inoculation with 5000 or 50.000 oocysts [64], they
were only detected 1 month post inoculation following
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study the oral inoculation with tissue cysts resulted in a
more rapid antibody response. However, this response was
similar to the one observed by McColgan et al. [54], which
saw IgG appear nine days after experimental infection
with tissue cysts [54]. This again supports the hypothesis
that the parasite passes the intestinal epithelial barrier
more quickly after an oral infection with tissue cysts,
although it can not be excluded that the earlier response
was a result of strain differences [8,14,55].
While the antibody response increased, and the para-
site seems to disappear from systemic lymphoid tissues,
also the IL-12 response in these tissues decreased or
became absent. This coincided with a decreased or nega-
tive antigen-specific IFN-gamma response in PP, PBMC
and popliteal LN cell cultures. Interestingly, these obser-
vations are in accordance with findings of Innes et al.
[17,52] who infected sheep subcutaneously with tachy-
zoites. They could not detect IFN-gamma anymore in
the lymph flow from lymph nodes draining the subcuta-
neous region from 11 days after infection onwards. At
that time they noticed a switch from predominantly
CD4+ proliferating lymphocytes to CD8+ proliferating
lymphocytes. In our study, antigen-specific IFN-gamma
responses were still present in MLN and spleen cell
cultures 21 dpi. Since MLN not only drain the gut but
also systemic sites such as the peritoneal cavity and since
the spleen is the secondary lymphoid organ draining the
blood both responses could play a role in controlling a
systemic infection occurring at this stage [52].
Conclusions
Our results indicate that parasites enter the cranial small
intestine the first days after infection. Three weeks later
T. gondii DNA could not be recovered anymore from
the intestine. This coincided with the increase of IgG1
and IgG2 antibodies and a decrease of the antigen-
specific IFN-gamma response in PP, PBMC and popliteal
LN. Furthermore, the experiments support a collaborate
role of humoral and cellular immunity in acute T. gondii
infections in sheep.
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